US grants almost $600 million to Moderna to “accelerate” bird flu vaccine trials
The United States government has allocated a significant investment of almost $600 million to the biopharmaceutical company Moderna to accelerate the development of vaccines based on messenger RNA (mRNA) against avian flu, with special emphasis on flu strains that could become a pandemic threat. This financial support is part of the Department of Health and … Read more